With the COVI-19 situation leading to unprecedented action from governments around the world, Anton Korinek offers advice to business leaders on responding to the crisis
Organisations around the world are working through how to respond to the novel coronavirus, posing one of the greatest challenges to leaders in a long time. Do they restrict travel? Doing so would have substantial financial implication, make months of preparation worthless and lower the morale of many stakeholders who enjoy travel. However, travel is what brought the coronavirus to the country in the first place — and what continues to spread it to new communities within the country.
What about instituting remote work procedures? In-person meetings and events may be a critical part of an organisation’s activities and an important part of the value it offers. Perhaps there are no known cases of the virus in a given community. However, once it does gain a foothold, social distancing is the only way to slow the spread. Carriers of the virus may unwittingly spread it for days before symptoms manifest themselves.
Above all, one of the greatest challenges is to balance an organisation’s economic concerns with the question of what is ethically the best course of action.
How we got there
The novel coronavirus was first identified in Wuhan, China, in December 2019. It jumped from bats via an intermediate host (most likely pangolins) that was traded in live animal markets to humans. The virus has officially been named SARS-CoV-2, and the disease that it causes has been named “coronavirus disease 2019” (abbreviated COVID-19). It spreads among humans via respiratory droplets from coughing as well as by touching infected surfaces. In an uncontrolled outbreak, the disease burden grows exponentially, with cases doubling approximately every six days. The incubation period, i.e. the time between when one is exposed to the virus and when one develops symptoms of disease, is from two to 14 days, with an average of five days.
Those infected usually present with a fever, a dry cough and general fatigue, frequently involving a mild form of pneumonia. About 15–20% of cases develop more severe pneumonia that requires hospitalisation, intensive care, and in many cases, mechanical ventilation. The latest World Health Organisation estimate of the fatality rate is 3.4%.
Why should organisations take action?
Some may argue that it’s up to individuals how much risk they’re willing to take. But becoming infected affects not only yourself but also endangers others, as infected individuals can spread the disease and expose their community to the substantial risks involved, up to and including premature death. There is thus a crucial ethical component to the public health precautions that individuals and organisations take. Economists call this public health aspect of infectious diseases an externality – in other words an effect on others that an individual or organisation that only cares about their own well-being is tempted to ignore. (A typical example of another type of externality is pollution – when an individual pollutes, society as a whole suffers.)
When an individual spreads the disease it does not impose any cost on them, but costs the newly infected dearly. In fact, the externalities of infectious diseases come in two forms: healthy people not taking sufficient precaution to avoid becoming infected (because they do not internalise the risks this will create for others) and exposed people not taking sufficient precaution to avoid spreading the disease.
Others may challenge the idea of whether to try to contain the virus at all. The disease seems unstoppable — it has spread around the world in a matter of weeks. Why go to such extreme lengths and incur enormous economic costs to try to prevent the unpreventable? Aren’t we all just caught up in a bad case of mass hysteria that is even more infectious — and pernicious — than the coronavirus itself? However, that argument neglects all the lives at risk and the extent to which an uncontrolled outbreak risks overwhelming medical resources and exacerbating the ultimate death toll.
What adds to the challenge on how to respond is the highly disproportionate impact of the disease on different people. The elderly and those with pre-existing conditions are at much greater risk of death from COVID-19 than others. For example, taking into account all the risk factors, a male in his 70s with a heart condition who contracts the virus has a risk of death that is significantly higher – perhaps in excess of 25%. (Useful information on mortality rate by demographics can be found on world statistics site Worldometer.)
Lessons from China and Italy
The experience of regions that have dealt with large outbreaks of COVID-19 in recent weeks, chiefly Wuhan and northern Italy, suggest two lessons.
- First, there is no place for fatalism in epidemiology. The fraction of the population that is ultimately infected by an epidemic is actually quite responsive to mitigation efforts. Wuhan has been able to get the virus under control by imposing tight quarantine measures on its citizens. Italy followed suit recently, with the outcome yet to be determined.
- Second, due to the exponential nature of the spread, an uncontrolled outbreak risks overwhelming a country’s health care infrastructure. About 15–20% of identified cases require hospital care. Even in the US, an uncontrolled outbreak would quickly exhaust the capacity of existing ICUs. If this were to happen, the fatality rate of the virus would be bound to rise significantly because sick patients could no longer be adequately treated. This suggests that it is critical to try to slow down the spread to keep the number of patients at any given time more manageable.
What we should be asking and answering
Organisations need to determine how to answer the following questions:
- What restrictions do you impose on your organisation’s inward and outward travel and why?
- At what point will you restrict in-person meetings and events at your organisation?
- Should you prepare your stakeholders for these potential changes now?
- What can you do to make the members of your organisation aware of the externalities that they impose on others, both if they are still healthy and in case they have become exposed to the disease?
The epidemiological realities of the disease have stark implications for organisations. Decisions made now will determine the way that stakeholders will work, travel and interact with each other in coming weeks and months, and it will determine the economic losses companies will experience. And as much as the virus will affect organisations, those organisations’ reaction to it will have a crucial effect on how fast and how widely COVID-19 will spread in their communities, and how many lives will be lost to the disease. This adds a crucial ethical component to the trade-off. Balancing the economic fall-out with this ethical dimension is the most significant leadership challenge of our time.
Anton Korinek is Associate Professor of Business Administration at Darden Business School